期刊文献+

PI3K/AKT/Bcl-2信号通路介导人前列腺癌PC-3细胞凋亡及苦参碱的干预效果分析 被引量:7

PI3K/AKT/Bcl-2 signaling pathway mediates human prostate cancer PC-3 cell apoptosis and analysis on matrine intervention effect
下载PDF
导出
摘要 目的探讨苦参碱(Mat)诱导人前列腺癌PC-3细胞凋亡的机制及其对磷脂酸肌醇3-激酶/丝氨酸苏氨酸激酶/B细胞淋巴瘤-2蛋白(PI3K/AKT/Bcl-2)信号通路的影响。方法采用不同质量-体积浓度(0.1、0.2、0.3、0.4、0.5 g/L)Mat处理PC-3细胞24、48、72 h,通过细胞增殖抑制试验检测PC-3细胞的增殖情况;采用流式细胞仪分析Mat对PC-3细胞周期分布的影响及凋亡率,运用蛋白质印迹法(Western blotting)检测用药前后细胞中PI3K、AKT、pAKT、Bax和Bcl-2蛋白的表达水平。结果经同一浓度Mat作用,48、72 h PC-3细胞增殖抑制率与24 h比较,差异均有统计学意义(P<0.05);处理48 h后,S期、G_0/G_1期0.2~0.5 g/L Mat组与对照组和0.1 g/L Mat组比较,差异均有统计学意义(P<0.05)。0.2~0.5 g/L Mat组细胞凋亡率明显高于对照组和0.1 g/L Mat组,差异均有统计学意义(P<0.05)。经0.1、0.2、0.3、0.4、0.5 g/L Mat处理48 h后,PC-3细胞PI3K、AKT、p-AKT、Bcl-2蛋白表达降低,Bax蛋白表达升高,差异均有统计学意义(P<0.05)。结论一定质量浓度范围Mat(0.2~0.5 g/L)能够抑制人前列腺癌PC-3细胞的增殖,Mat通过影响PI3K/AKT/Bcl-2信号通路诱导人前列腺癌PC-3细胞凋亡。 Objective To investigate the mechanism of matrine(Mat) inducing human prostate cancer PC-3 cells apoptosis and its effect on PI3K/AKT/Bcl-2 signaling pathway. Methods PC-3 cells were processed by different concentration of Mat(0.1,0.2,0.3,0.4,0.5 g/L) for 24,48,72 h. The PC-3 cell proliferation was detected by methyl thiazolyl tetrazolium.The effect of Mat on PC-3 cells cycle distribution and apoptosis rate were detected by flow cytometry. The expression levels of PI3 K,AKT,p-AKT,Bax and Bcl-2 protein before and after medication were analyzed by Western blot. Results By the action with the same concentration of Mat,the PC-3 cellular apoptosis rate had statistical difference between 48,72 h with 24 h(P〈0.05);after 48 h of Mat treatment,the difference between the 0.2-0.5 g/L Mat group with control group and 0.1g/L Mat group at the stage S and G_0/G_1 had statistical significance(P〈0.05).The apoptosis rate in the 0.2~0.5 g/L Mat group was significantly higher than that in the control group and 0.1 g/L Mat group,the differences were statistically significant(P〈0.05).After 48 h of 0.1, 0.2, 0.3, 0.4, 0.5 g/L Mat treatment,the expression of PI3 K,AKT,p-AKT and Bcl-2 protein in PC-3 cells were decreased,while Bax protein expression was increased,the differences were statistically significant(P〈0.05). Conclusion In a certain mass-volume concentration range(0.2 ~0.5 g/L),Mat can inhibit human prostate cancer PC-3 cells proliferation,Mat induces human prostate cancer PC-3 cells apoptosis by influencing PI3K/AKT/Bcl-2 signal pathway.
作者 杨雪松 邓显忠 鲜述彦 曾德朗 Yang Xuesong Deng Xianzhong Xian Shuyan Zeng Delang(Department of Urological Surgery, Afiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, Chin)
出处 《现代医药卫生》 2017年第15期2266-2269,共4页 Journal of Modern Medicine & Health
关键词 苦参碱 前列腺肿瘤 细胞凋亡 细胞培养 Matrine Prostatic neoplasms Apoptosis Cell culture
  • 相关文献

参考文献4

二级参考文献62

  • 1李季泓.黄芪的药理作用研究[J].辽宁中医药大学学报,2009,11(4):188-189. 被引量:72
  • 2周晓光,张杰.前列腺癌内分泌治疗现状与研究进展[J].世界临床药物,2009,30(11):641-645. 被引量:2
  • 3Oster G, Lamerato L, Glass AG, et aL Natural history of skeletal related events in patients with breast, lung, or prostate cancer and metastases to bone:a 15-year study in two large US health systems. Support Care Cancer 2013; 21(12): 3279-3286.
  • 4Carlin BI, Andriole GL. The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma. Cancer 2000; 88 (12 Suppl): 2989-2994.
  • 5Rosen LS, Gordon D, Kaminski M, et al. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double blind, comparative trial. Cancer J 2001 ; 7(5): 377-387.
  • 6Buga S, Sarria JE. The management of pain in metastatic bone disease. Cancer Control 2012; 19(2): 154-166.
  • 7Hamdy NA, Papapoulos SE. The palliative management of skeletal metastases in prostate cancer: Use of boneseeking radionuclides and bisphosphonates. Semin NuelMed2001; 31(1): 62-68.
  • 8Boissier S, Ferreras M, Peyruchaud O, et M. Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases. Cancer Res 2000; 60(11): 2949-2954.
  • 9Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016 [J]. CA Cancer J Clin, 2016, 66(1): 7-30. doi: 10.3322/ caac,21332.
  • 10Shi J, Zhuang Y, Liu Y, et al. Systematic analysis on the GSTM 1 null phenotype and prostate cancer risk in Chi- nese people [J]. Asian Pac J Cancer Prey, 2015, 16(5): 2009-2011.

共引文献20

同被引文献122

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部